News
Oceania Vice President, Ana Svensson says many New Zealanders have weight issues. She says about 2.8 million people are either overweight or obese - and 170 thousand suffer related cardiovascular ...
Each Mounjaro KwikPen delivers four fixed doses of 0.6 mL and will available in the Indian market in six dose strengths of 2 ...
Guest blog by Joachim Bjørkmann from Ministry of Foreign Affairs Denmark as part of our #UnleashInnovation week 2025.
Glancy Prongay & Murray LLP ("GPM"), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Sookdeo v. Hims & Hers ...
The global health landscape is evolving with Brazil battling bird flu-related trade restrictions, Nestle USA eliminating ...
Shares in Denmark's pharmaceutical giant Novo Nordisk ( NVO -4.99%) were lower by 4% as of 11 a.m. ET today. The move comes ...
Synthetic food dyes are added to 1 in 5 packaged foods and drinks sold by top U.S. food manufacturers, a new study says.
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...
NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE: NVO) ...
Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...
LOS ANGELES (Reuters) -Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results